ReviewACS omega2022
Heteroatom Codoped Graphene: The Importance of Nitrogen.
Review in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Strategically Functionalised Graphene Surfaces for the Selective Removal of Polycyclic Aromatic Hydrocarbons From Diverse Aquatic Systems.Chemical record (New York, N.Y.) · 2026Review
- Investigating the Effect of Active Site Density in Transition Metal-Doped Graphene on CO Gas Sensing Performance: A DFT Study.Sensors (Basel, Switzerland) · 2026Article
- Harnessing formaldehyde detection: novel metal-doped coronene sensors to combat pollution and enable early lung cancer diagnosis.Journal of computer-aided molecular design · 2026Article
- From Theory to Experiment: Reviewing the Role of Graphene in Li-Ion Batteries Through Density Functional Theory.Nanomaterials (Basel, Switzerland) · 2025Review
- Porous carbons: a class of nanomaterials for efficient adsorption-based hydrogen storage.RSC applied interfaces · 2025Review
- Optical bio/chemical sensors for vitamin BBeilstein journal of nanotechnology · 2025Review
- Scalable bottom-up synthesis of Co-Ni-doped graphene.Science advances · 2024Article
- Stannate-Based Materials as Anodes in Lithium-Ion and Sodium-Ion Batteries: A Review.Molecules (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although graphene has exceptional properties, they are not enough to solve the extensive list of pressing world problems. The substitutional doping of graphene using heteroatoms is one of the preferred methods to adjust the physicochemical properties of graphene. Much effort has been made to dope graphene using a single dopant. However, in recent years, substantial efforts have been made to dope graphene using two or more dopants. This review summarizes all the hard work done to synthesize, characterize, and develop new technologies using codoped, tridoped, and quaternary doped graphene. First, I discuss a simple question that has a complicated answer: When can an atom be considered a dopant? Then, I briefly discuss the single atom doped graphene as a starting point for this review's primary objective: codoped or dual-doped graphene. I extend the discussion to include tridoped and quaternary doped graphene. I review most of the systems that have been synthesized or studied theoretically and the areas in which they have been used to develop new technologies. Finally, I discuss the challenges and prospects that will shape the future of this fascinating field. It will be shown that most of the graphene systems that have been reported involve the use of nitrogen, and much effort is needed to develop codoped graphene systems that do not rely on the stabilizing effects of nitrogen. I expect that this review will contribute to introducing more researchers to this fascinating field and enlarge the list of codoped graphene systems that have been synthesized.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.